guest ::
| Home > Publications database > Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. > print |
| Home > Publications database > Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. > print |
| 001 | 303204 | ||
| 005 | 20250803021847.0 | ||
| 024 | 7 | _ | |a 10.1038/s41419-025-07863-y |2 doi |
| 024 | 7 | _ | |a pmid:40715046 |2 pmid |
| 024 | 7 | _ | |a altmetric:179727019 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-01555 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Wang, Yiman |0 P:(DE-He78)ada7e359a1f7451130dbc79595227bec |b 0 |e First author |
| 245 | _ | _ | |a Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. |
| 260 | _ | _ | |a London [u.a.] |c 2025 |b Nature Publishing Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1753781075_3433 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a DKFZ-ZMBH Alliance / #EA:A370#LA:A370# |
| 520 | _ | _ | |a Melanoma is an aggressive skin cancer and highly lethal at advanced stages due to its high tumorigenicity and metastatic capacity. Changing the phenotype of cancer cells from one lineage to another, a process called transdifferentiation, leads to tumor cell reversion, which goes along with a drastic reduction of their tumorigenicity. Via ectopic overexpression of four neuronal transcription factors, we transdifferentiated melanoma cells into neuron-like cells expressing neuronal markers and showing a neuron-like morphology. Moreover, the tumorigenic and metastatic potential of transdifferentiated cells in vitro and in vivo was significantly reduced. Transdifferentiated cells were also more sensitive to radiotherapy compared with their parental counterparts. We conclude that transdifferentiation of cancer cells into terminally differentiated neuron-like cells might represent a prospective new therapeutic approach for the treatment of melanoma. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Liu, Ke |0 P:(DE-He78)f0eba78b0ea9f77651e698dcb699fa5f |b 1 |
| 700 | 1 | _ | |a Zhang, Yuxin |0 P:(DE-He78)66623fe2fa2e29982369f4d828fec9bd |b 2 |u dkfz |
| 700 | 1 | _ | |a Novak, Daniel |0 P:(DE-He78)5f0b1c9863f44d0695555ee3c22b9758 |b 3 |u dkfz |
| 700 | 1 | _ | |a Federico, Aniello |0 P:(DE-He78)32c5110cd42ee8a96b18a3e8909bd0a9 |b 4 |u dkfz |
| 700 | 1 | _ | |a Xu, Cai |0 P:(DE-He78)776d1fafe53e21bcad1a68092996ba60 |b 5 |
| 700 | 1 | _ | |a Horschitz, Sandra |0 P:(DE-He78)d259a40fda30d4e1fa043ad04370fd06 |b 6 |u dkfz |
| 700 | 1 | _ | |a Vierthaler, Marlene |0 P:(DE-He78)61de47f47323d5d0b1700e8213e5179f |b 7 |
| 700 | 1 | _ | |a Sun, Qian |0 P:(DE-He78)f1f0076fc72606659a5df2605acce91b |b 8 |u dkfz |
| 700 | 1 | _ | |a Wang, Nina |0 P:(DE-He78)f3d19b02f83230d528305e528fcd72c8 |b 9 |u dkfz |
| 700 | 1 | _ | |a Poelchen, Juliane |0 P:(DE-He78)88a268b9173c651561385cddfdf819fa |b 10 |
| 700 | 1 | _ | |a Steinfass, Tamara |0 P:(DE-He78)a65fa5fbdeff5a1bb6ee7de07b820488 |b 11 |
| 700 | 1 | _ | |a Hüser, Laura |0 P:(DE-He78)78e29fad12f1be2fe3d0a8d411f97211 |b 12 |
| 700 | 1 | _ | |a Mall, Moritz |0 P:(DE-He78)cb70d67b37a3b9239e352b7fbead37f5 |b 13 |u dkfz |
| 700 | 1 | _ | |a Umansky, Viktor |0 P:(DE-He78)38be34240daf8b47325afc7910e77f7b |b 14 |u dkfz |
| 700 | 1 | _ | |a Utikal, Jochen |0 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3 |b 15 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1038/s41419-025-07863-y |g Vol. 16, no. 1, p. 563 |0 PERI:(DE-600)2541626-1 |n 1 |p 563 |t Cell death & disease |v 16 |y 2025 |x 2041-4889 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:303204 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)ada7e359a1f7451130dbc79595227bec |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)f0eba78b0ea9f77651e698dcb699fa5f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)66623fe2fa2e29982369f4d828fec9bd |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)5f0b1c9863f44d0695555ee3c22b9758 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)32c5110cd42ee8a96b18a3e8909bd0a9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)776d1fafe53e21bcad1a68092996ba60 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)d259a40fda30d4e1fa043ad04370fd06 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)61de47f47323d5d0b1700e8213e5179f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)f1f0076fc72606659a5df2605acce91b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)f3d19b02f83230d528305e528fcd72c8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)88a268b9173c651561385cddfdf819fa |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)a65fa5fbdeff5a1bb6ee7de07b820488 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)78e29fad12f1be2fe3d0a8d411f97211 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)cb70d67b37a3b9239e352b7fbead37f5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)38be34240daf8b47325afc7910e77f7b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL DEATH DIS : 2022 |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-04-10T15:36:07Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-04-10T15:36:07Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2024-04-10T15:36:07Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2024-04-10T15:36:07Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-01 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-01 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL DEATH DIS : 2022 |d 2025-01-01 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2025-01-01 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2025-01-01 |
| 920 | 2 | _ | |0 I:(DE-He78)A370-20160331 |k A370 |l KKE Dermatoonkologie |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)A370-20160331 |k A370 |l KKE Dermatoonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A370-20160331 |k A370 |l KKE Dermatoonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)E220-20160331 |k E220 |l E220 Radioonkologie Radiobiologie |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)A340-20160331 |k A340 |l A340 NWG Engeneering von Zellidentitäten und Krankheitsmodellen |x 4 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A370-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E220-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)A340-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|